[go: up one dir, main page]

UY29221A1 - DERIVATIVES OF OCTAHIDROPIRROLO (3,4-C) PIRROL - Google Patents

DERIVATIVES OF OCTAHIDROPIRROLO (3,4-C) PIRROL

Info

Publication number
UY29221A1
UY29221A1 UY29221A UY29221A UY29221A1 UY 29221 A1 UY29221 A1 UY 29221A1 UY 29221 A UY29221 A UY 29221A UY 29221 A UY29221 A UY 29221A UY 29221 A1 UY29221 A1 UY 29221A1
Authority
UY
Uruguay
Prior art keywords
derivatives
octahidropirrolo
pirrol
octahydropyrrolo
processes
Prior art date
Application number
UY29221A
Other languages
Spanish (es)
Inventor
Charlotte Alice Louise Lane
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35985757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29221(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04106044A external-priority patent/EP1671972A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of UY29221A1 publication Critical patent/UY29221A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a derivados de octahidropirrolo(3,4-c)pirrol de fórmula (I): y a procedimientos para su preparación, a composiciones que los contienen y a sus usos.The present invention relates to octahydropyrrolo (3,4-c) pyrrole derivatives of formula (I): and to processes for their preparation, compositions containing them and their uses.

UY29221A 2004-11-24 2005-11-21 DERIVATIVES OF OCTAHIDROPIRROLO (3,4-C) PIRROL UY29221A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106044A EP1671972A1 (en) 2004-11-24 2004-11-24 Octahydropyrrolo[3,4-c]pyrrole derivatives
EP05100474 2005-01-26

Publications (1)

Publication Number Publication Date
UY29221A1 true UY29221A1 (en) 2006-06-30

Family

ID=35985757

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29221A UY29221A1 (en) 2004-11-24 2005-11-21 DERIVATIVES OF OCTAHIDROPIRROLO (3,4-C) PIRROL

Country Status (12)

Country Link
EP (1) EP1846409A1 (en)
JP (1) JP2008520644A (en)
AR (1) AR054707A1 (en)
CA (1) CA2587141A1 (en)
GT (1) GT200500340A (en)
NL (1) NL1030503C2 (en)
PA (1) PA8653801A1 (en)
PE (1) PE20061055A1 (en)
SV (1) SV2007002315A (en)
TW (1) TW200626600A (en)
UY (1) UY29221A1 (en)
WO (1) WO2006056848A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079694B1 (en) 2006-12-28 2017-03-01 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
EP2460794A4 (en) * 2009-07-31 2013-01-23 Shionogi & Co Pharmaceutical composition containing fused hetero-ring derivative
US8680275B2 (en) 2009-10-23 2014-03-25 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
KR101859409B1 (en) 2009-10-23 2018-05-18 얀센 파마슈티카 엔.브이. DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
US9062044B2 (en) 2009-10-23 2015-06-23 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
ES2683380T3 (en) 2012-06-08 2018-09-26 Sensorion H4 receptor inhibitors to treat tinnitus
PT3426251T (en) 2016-03-10 2022-07-27 Janssen Pharmaceutica Nv METHODS OF TREATMENT OF DEPRESSION USING OREXIN-2 RECEPTOR ANTAGONISTS
WO2019152883A1 (en) 2018-02-02 2019-08-08 Padforward Llc Inhibitors of protein arginine deiminases
CN117143245B (en) * 2023-08-28 2025-11-28 杭州旭科生物技术有限公司 Anti-fluoxetine antibodies or antigen binding fragments thereof and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2620341A (en) * 1949-03-24 1952-12-02 Burroughs Wellcome Co N,n-dialkyl-quinoline-4-carboxamidines
FI974180A0 (en) * 1995-05-11 1997-11-10 Upjohn Co Spirocyclic and bicyclic diazinyl and carbazinyloxazolidinones
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
MXPA03008109A (en) * 2001-03-07 2003-12-12 Pfizer Prod Inc Modulators of chemokine receptor activity.
JP4544820B2 (en) * 2001-03-09 2010-09-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Heterocyclic compounds
AU2003272285A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica, N.V. Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
CA2497788A1 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
UA79309C2 (en) * 2002-09-06 2007-06-11 Janssen Pharmaceutica Nv Heterocyclic compounds

Also Published As

Publication number Publication date
NL1030503A1 (en) 2006-05-29
PA8653801A1 (en) 2006-06-02
TW200626600A (en) 2006-08-01
AR054707A1 (en) 2007-07-11
PE20061055A1 (en) 2006-11-09
JP2008520644A (en) 2008-06-19
EP1846409A1 (en) 2007-10-24
WO2006056848A1 (en) 2006-06-01
NL1030503C2 (en) 2006-11-28
SV2007002315A (en) 2007-02-16
CA2587141A1 (en) 2006-06-01
GT200500340A (en) 2006-07-13

Similar Documents

Publication Publication Date Title
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
CU20090072A7 (en) L-GLUTAMIC ACID MARKED WITH [F-18], L-GLUTAMINE MARKED WITH [F-18], ITS DERIVATIVES AND ITS USE, AS WELL AS PROCEDURES FOR PREPARATION
UY29795A1 (en) ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
AR057325A1 (en) SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES
ECSP066667A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
ECSP077271A (en) PIRIMIDINE DERIVATIVES
HN1999000106A (en) HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS.
UY30206A1 (en) DIAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ECSP077259A (en) PIRIMIDINE DERIVATIVES
BRPI0408347B8 (en) pyrimidine derivatives, their use, and pharmaceutical composition and combination
ECSP066541A (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
CO6390082A2 (en) ORGANIC COMPOUNDS
CU23415B7 (en) DERIVATIVES OF 2,6- QUINOLINILO AND 2,6- NAFTILO, PROCESSES FOR THEIR PREPARATION AND ITS USES
UY29360A1 (en) NEW DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS.
UY29004A1 (en) SUBSTITUTED DERIVED COMPOUNDS OF ACIDS, GLYCIN AND ALANINE; PROCEDURE FOR PREPARATION AND USE.
CR9954A (en) PIRAZINE DERIVATIVES
UY29002A1 (en) NEW HIDANTOINE DERIVATIVES, PARASU PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY
UY30808A1 (en) BENZOTIAZOLONAS DERIVATIVES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
HN2008000088A (en) HETEROCICLICOS OF 1,4-DIHIDROPIRIDINA- FUSIONADA, PROCESSES TO PREPARE THE SAME, ITS USE AND THE COMPOSITIONS THAT CONTAIN THEM.
UY27894A1 (en) CINAMIDE DERIVATIVES
ECSP088140A (en) NEW PIRIDINE ANALOGS
UY29767A1 (en) BENZOTIAZOLONAS DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
AR116001A2 (en) PHARMACEUTICAL COMPOSITION 271
UY29221A1 (en) DERIVATIVES OF OCTAHIDROPIRROLO (3,4-C) PIRROL
CR9391A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160526